Pancreatic Cancer Whole Blood

<h2>Pancreatic Cancer Whole Blood for Research</h2>
Pancreatic cancer is an aggressive malignancy frequently driven by KRAS mutations, with limited early detection options making circulating biomarker research a high priority. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed pancreatic cancer diagnosis for oncology biomarker research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed pancreatic cancer donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed diagnosis, including KRAS status and stage where available</li><li>Demographics: age, sex assigned at birth, ethnicity</li><li>Relevant medical and treatment history</li></ul>
<h3>Applications</h3>
<ul><li>KRAS mutation and early-detection biomarker research</li><li>Circulating tumor DNA and liquid-biopsy studies</li><li>Gene expression and transcriptomic analysis</li><li>Chemotherapy and targeted therapy response research</li></ul>
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
Pancreatic cancer whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.